[{"begin": 116, "end": 140, "text": ", Munoz, L., Kassiou, M.", "tokenized_text": ", Munoz , L . , Kassiou , M .", "type": "authors", "id": 0}, {"begin": 142, "end": 146, "text": "2017", "tokenized_text": "2017", "type": "year", "id": 1}, {"begin": 149, "end": 336, "text": "Structural optimization and pharmacological evaluation of inhibitors targeting dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) and CDC-like kinases (CLK) inglioblastoma", "tokenized_text": "Structural optimization and pharmacological evaluation of inhibitors targeting dual - specificity tyrosine phosphorylation - regulated kinases ( DYRK ) and CDC - like kinases ( CLK ) inglioblastoma", "type": "title", "id": 2}, {"begin": 338, "end": 368, "text": "Journal of Medicinal Chemistry", "tokenized_text": "Journal of Medicinal Chemistry", "type": "venue", "id": 3}, {"begin": 0, "end": 116, "text": "Zhou, Q., Phoa, A., Abbassi, R., Hoque, M., Reekie, T., Font Sadurni, J., Ryan, R., Stringer, B., Day, B., Johns, T.", "tokenized_text": "Zhou , Q . , Phoa , A . , Abbassi , R . , Hoque , M . , Reekie , T . , Font Sadurni , J . , Ryan , R . , Stringer , B . , Day , B . , Johns , T .", "type": "authors", "id": 4}]